Related Experiment Videos
Colorectal carcinoma: is screening possible?
1Unit of Secondary Prevention and Screening, National Institute for Cancer Research, Largo R. Benzi 10, I-16132 Genoa, Italy. luigina.bonelli@istge.it
Techniques in Coloproctology
|January 25, 2005
Summary
Early diagnosis of colorectal cancer (CRC) through screening is crucial for reducing mortality. Various screening tests are available for average-risk individuals, with population-based programs being discussed.
Area of Science:
- Oncology
- Gastroenterology
- Public Health
Background:
- Colorectal cancer (CRC) is a leading cause of cancer-related mortality in Western countries, particularly in the EU.
- Approximately 220,000 new cases and 112,000 deaths occur annually in the EU.
- CRC typically develops from adenomatous polyps over time, with a 2% annual risk of progression to invasive cancer.
Purpose of the Study:
- To highlight the significance of early diagnosis in reducing CRC mortality.
- To review available screening methods for average-risk populations.
- To discuss challenges associated with large-scale CRC screening programs.
Main Methods:
- Review of existing literature on CRC screening modalities.
- Analysis of epidemiological data for CRC incidence and mortality in the EU.
- Discussion of the adenoma-carcinoma sequence and disease progression.
Main Results:
- Early diagnosis is the most effective strategy to decrease CRC-related deaths.
- Available screening tests include faecal occult blood tests, flexible sigmoidoscopy, and colonoscopy.
- Population-based screening programs face implementation challenges.
Conclusions:
- Implementing effective CRC screening programs is vital for public health.
- A range of diagnostic tools can aid in the early detection of colorectal cancer.
- Further discussion is needed on the large-scale introduction of CRC screening initiatives.